Francisca I Camacho

Summary

Country: Spain

Publications

  1. ncbi Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases
    Francisca I Camacho
    Lymphoma Group, Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
    Am J Surg Pathol 27:762-71. 2003
  2. ncbi Aberrant Bcl6 protein expression in mantle cell lymphoma
    Francisca I Camacho
    Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, C Melchior Fernandez Almagro 3, E 28029 Madrid, Spain
    Am J Surg Pathol 28:1051-6. 2004
  3. doi TCL1A expression delineates biological and clinical variability in B-cell lymphoma
    Mohit Aggarwal
    Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Mod Pathol 22:206-15. 2009
  4. doi Somatic hypermutation signature in B-cell low-grade lymphomas
    Lorraine Tracey
    Molecular Pathology Programme, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
    Haematologica 93:1186-94. 2008
  5. ncbi The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival
    Nerea Martinez
    Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
    Cancer Res 63:8226-32. 2003
  6. ncbi Functional signatures identified in B-cell non-Hodgkin lymphoma profiles
    Mohit Aggarwal
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Leuk Lymphoma 50:1699-708. 2009
  7. ncbi Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis
    Elena Ruiz-Ballesteros
    Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, C Melchor Fernandez Almagro 3, E 28 029 Madrid, Spain
    Blood 106:1831-8. 2005
  8. ncbi Peripheral T-cell lymphoma with follicular T-cell markers
    Socorro Maria Rodriguez-Pinilla
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Am J Surg Pathol 32:1787-99. 2008
  9. ncbi Variability in the degree of expression of phosphorylated IkappaBalpha in chronic lymphocytic leukemia cases with nodal involvement
    Antonia Rodriguez
    Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
    Clin Cancer Res 10:6796-806. 2004
  10. ncbi Silencing of the p18INK4c gene by promoter hypermethylation in Reed-Sternberg cells in Hodgkin lymphomas
    Abel Sanchez-Aguilera
    Lymphoma Group, Molecular Pathology Program, and the Immunohistochemistry and Histology Unit, Centro Nacional de Investigaciones Oncologicas, E 28029 Madrid, Spain
    Blood 103:2351-7. 2004

Collaborators

Detail Information

Publications25

  1. ncbi Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases
    Francisca I Camacho
    Lymphoma Group, Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
    Am J Surg Pathol 27:762-71. 2003
    ..Molecular and immunohistochemical data obtained in this study strongly imply that there is significant heterogeneity among the cases included in the category termed nodal marginal zone lymphoma...
  2. ncbi Aberrant Bcl6 protein expression in mantle cell lymphoma
    Francisca I Camacho
    Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, C Melchior Fernandez Almagro 3, E 28029 Madrid, Spain
    Am J Surg Pathol 28:1051-6. 2004
    ..Chromosomal alterations involving 3q27 seem to be responsible for this increased Bcl6 expression, which needs to be considered when Bcl6 is used in lymphoma diagnosis...
  3. doi TCL1A expression delineates biological and clinical variability in B-cell lymphoma
    Mohit Aggarwal
    Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Mod Pathol 22:206-15. 2009
    ....
  4. doi Somatic hypermutation signature in B-cell low-grade lymphomas
    Lorraine Tracey
    Molecular Pathology Programme, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
    Haematologica 93:1186-94. 2008
    ....
  5. ncbi The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival
    Nerea Martinez
    Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
    Cancer Res 63:8226-32. 2003
    ..In conclusion, MCL seems to combine a disease-specific signature and different sets of genes of which the expression is associated with key clinical, molecular, and immunophenotypical events...
  6. ncbi Functional signatures identified in B-cell non-Hodgkin lymphoma profiles
    Mohit Aggarwal
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Leuk Lymphoma 50:1699-708. 2009
    ..A specific attention was paid to the analysis of BCR and coregulated pathways, defining molecular heterogeneity within multiple B-cell lymphoma types...
  7. ncbi Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis
    Elena Ruiz-Ballesteros
    Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, C Melchor Fernandez Almagro 3, E 28 029 Madrid, Spain
    Blood 106:1831-8. 2005
    ..Shorter survival was associated with CD38 expression, naive IgV(H) genes, and the expression of a set of NF-kappaB pathway genes, including TRAF5, REL, and PKCA...
  8. ncbi Peripheral T-cell lymphoma with follicular T-cell markers
    Socorro Maria Rodriguez-Pinilla
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Am J Surg Pathol 32:1787-99. 2008
    ..The aim of this study was to establish whether other PTCL subgroups also express TFH cell markers...
  9. ncbi Variability in the degree of expression of phosphorylated IkappaBalpha in chronic lymphocytic leukemia cases with nodal involvement
    Antonia Rodriguez
    Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
    Clin Cancer Res 10:6796-806. 2004
    ....
  10. ncbi Silencing of the p18INK4c gene by promoter hypermethylation in Reed-Sternberg cells in Hodgkin lymphomas
    Abel Sanchez-Aguilera
    Lymphoma Group, Molecular Pathology Program, and the Immunohistochemistry and Histology Unit, Centro Nacional de Investigaciones Oncologicas, E 28029 Madrid, Spain
    Blood 103:2351-7. 2004
    ..These findings suggest that p18INK4c may function as a tumor suppressor gene in HL, and its inactivation may contribute to the cell cycle deregulation and defective terminal differentiation characteristic of the RS cells...
  11. ncbi Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations
    Francisca I Camacho
    Centro Nacional de Investigaciones Oncologicas, Molecular Pathology Program, Madrid, Spain
    Blood 101:4042-6. 2003
    ....
  12. ncbi Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas
    Santiago Montes-Moreno
    Lymphoma Group, Spanish National Cancer Centre CNIO, Madrid, Spain
    Blood 111:351-8. 2008
    ..The results of RNA and protein expression should prompt further investigation into the role of Gcet1 in regulating B-cell survival...
  13. ncbi Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively
    Lorraine Tracey
    Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
    J Pathol 206:123-34. 2005
    ..Meanwhile, in chronic lymphocytic leukaemia (CLL)-derived lymphocytes, NF-kappaB inhibition resulted in a marked decrease in BCL2 expression...
  14. doi Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cells
    Francisca I Camacho
    Department of Pathology, Hospital Universitario de Getafe, Carretera de Toledo, Getafe, Madrid, Spain
    Mod Pathol 24:698-707. 2011
    ..This not only confirms that a group of FL cases may have a very good clinical course, but also indicates that this group can be identified using this integrated clinical and immunohistochemical approach...
  15. ncbi Large B-cell lymphoma presenting in the spleen: identification of different clinicopathologic conditions
    Manuela Mollejo
    Lymphoma Group, Molecular Pathology Program, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
    Am J Surg Pathol 27:895-902. 2003
    ..Additionally, they provide evidence that clinical presentation as a tumor confined to the spleen and the hilar lymph nodes is associated with lower aggressivity...
  16. ncbi Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas
    Javier Silva
    Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Madrid, Spain
    Clin Cancer Res 12:6929-36. 2006
    ..Here, we examine whether these in vitro findings can be extrapolated to the in vivo situation...
  17. ncbi Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays
    Juan F Garcia
    Lymphoma Group, Molecular Pathology Program, and Immunohistochemistry and Histology Unit, Centro Nacional de Investigaciones Oncologicas CNIO, Madrid, Spain
    Blood 101:681-9. 2003
    ..This appears to determine the viability of the tumoral cells and the clinical outcome...
  18. pmc Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling
    Yolanda Ruano
    Genetics Department, Hospital Virgen de la Salud, Avda, Barber 30, 45004 Toledo, Spain
    Mol Cancer 5:39. 2006
    ..However, the limited resolution of these techniques has precluded the precise identification of detailed specific gene copy number alterations...
  19. doi Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme
    Yolanda Ruano
    Genetics Department, Virgen de la Salud Hospital, Toledo, Spain
    Cancer 112:1575-84. 2008
    ....
  20. doi Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia
    Bibiana I Ferreira
    Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncologicas CNIO, Melchor Fernandez Almagro, 3, 28029 Madrid, Spain
    Haematologica 93:670-9. 2008
    ..Our objective was to search for genomic features that allow a better molecular identification of the different types of lymphoma studied...
  21. ncbi Nuclear bcl10 expression characterizes a group of ocular adnexa MALT lymphomas with shorter failure-free survival
    Renato Franco
    Pathology Unit, National Cancer Institute Giovanni Pascale, Naples, Italy
    Mod Pathol 19:1055-67. 2006
    ..Moreover, patients with tumoral bcl10 nuclear expression showed shorter failure-free survival...
  22. ncbi Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma?
    Blanca Espinet
    Servei de Patologia Laboratori de Citogenetica i Biologia Molecular, Laboratori de Citologia Hematologica, Laboratori de Patologia, Hospital del Mar, IMAS, URNHE, PRBB, Barcelona 08003, Spain
    Hum Pathol 36:1232-7. 2005
    ..The existence of such asymptomatic patients with an indolent clinical course should induce a strict clinical judgment in terms of therapeutic decisions...
  23. ncbi IgV(H) and bcl6 somatic mutation analysis reveals the heterogeneity of cutaneous B-cell lymphoma, and indicates the presence of undisclosed local antigens
    Renato Franco
    Istituto dei Tumori G Pascale, Napoli, Italy
    Mod Pathol 17:623-30. 2004
    ..The biased usage of V(H)2-70, the low rate of replacement mutation in the FR, and the presence of ongoing mutation imply that local antigens could modulate the growth of primary cutaneous BCL...
  24. ncbi Nodal and splenic marginal zone B cell lymphomas
    Manuela Mollejo
    Department of Genetics and Pathology, Hospital Virgen de la Salud, Toledo, Spain
    Hematol Oncol 23:108-18. 2005
    ..Specific therapeutic protocols and prognostic factors are required to more precisely define this tumour...
  25. ncbi The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma
    Tomas Alvaro
    Department of Pathology, Hospital de Tortosa Verge de la Cinta, C Esplanetes n 14, 43500 Tortosa, Spain
    Haematologica 91:1605-12. 2006
    ..The aim of this study was to determine the extent to which macrophages are present in FL and to investigate the expression of STAT1 in these cells...